{
    "clinical_study": {
        "@rank": "127816", 
        "arm_group": [
            {
                "arm_group_label": "Lubiprostone", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the pharmacodynamics and tolerability of a liquid formulation of lubiprostone,\n      as compared to matching placebo, when administered orally to subjects with chronic\n      idiopathic constipation. Additionally, liquid formulation pharmacokinetics, including a\n      comparison of fed and fasted pharmacokinetics, of the liquid formulation will be performed\n      in a subset of subjects."
        }, 
        "brief_title": "Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Idiopathic Constipation", 
        "condition_browse": {
            "mesh_term": "Constipation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Medically-confirmed diagnosis of chronic idiopathic constipation\n\n          -  Willing to discontinue use of prescribed or over-the-counter (OTC) medication that\n             affects gastrointestinal motility during the study\n\n          -  Stable dose of selective serotonin re-uptake inhibitors (SSRIs), serotonin-specific\n             reuptake inhibitor (SNRIs), or monoamine oxidase inhibitors (MAO) inhibitors\n\n        Exclusion Criteria:\n\n          -  Any gastrointestinal (GI) condition, other than constipation, affecting GI motility\n             or defecation.\n\n          -  Medical/surgical condition that might interfere with the absorption, distribution,\n             metabolism, or excretion of the study medication."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "164", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01993875", 
            "org_study_id": "SCMP-0211-301"
        }, 
        "intervention": [
            {
                "arm_group_label": "Lubiprostone", 
                "description": "Liquid formulation, 12 mcg x 2 pumps administered orally twice daily (BID)", 
                "intervention_name": "Lubiprostone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Matching liquid placebo, 0 mcg x 2 pumps administered orally twice daily (BID)", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "April 24, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Anniston", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "36207"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Anaheim", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92801"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Deland", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32720"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hollywood", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33024"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32809"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "South Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33143"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Overland Park", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "66212"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marlton", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08053"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27612"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84106"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Bend", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53095"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Pharmacodynamics, Pharmacokinetics, and Tolerability of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation", 
        "overall_official": {
            "affiliation": "Wake Research Associates, LLC", 
            "last_name": "Charles F Barish, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Spontaneous Bowel Movement frequency rate", 
            "safety_issue": "No", 
            "time_frame": "Week 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01993875"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in Spontaneous Bowel Movement frequency rate", 
                "safety_issue": "No", 
                "time_frame": "Week 1"
            }, 
            {
                "measure": "Overall and mean change from baseline in stool consistency", 
                "safety_issue": "No", 
                "time_frame": "Week 1"
            }, 
            {
                "measure": "Overall and mean change from baseline in straining", 
                "safety_issue": "No", 
                "time_frame": "Week 1"
            }
        ], 
        "source": "Sucampo Pharma Americas, LLC", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Sucampo Pharma Americas, LLC", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Takeda", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Sucampo AG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}